EP1583831A2 - Nouveau procede a haut debit de production et de purification de cibles d'arnc marquees pour l'analyse de l'expression genique - Google Patents

Nouveau procede a haut debit de production et de purification de cibles d'arnc marquees pour l'analyse de l'expression genique

Info

Publication number
EP1583831A2
EP1583831A2 EP04701455A EP04701455A EP1583831A2 EP 1583831 A2 EP1583831 A2 EP 1583831A2 EP 04701455 A EP04701455 A EP 04701455A EP 04701455 A EP04701455 A EP 04701455A EP 1583831 A2 EP1583831 A2 EP 1583831A2
Authority
EP
European Patent Office
Prior art keywords
labeled
compartment
cdna
substantially pure
synthesized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04701455A
Other languages
German (de)
English (en)
Inventor
Joseph Peter Luciano, Jr.
Eugene L. Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of EP1583831A2 publication Critical patent/EP1583831A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Definitions

  • This invention relates to a method of rapid preparation of labeled and unlabeled target polynucleotides suitable for gene expression analysis.
  • targets are generated in a single, multiple-compartment format container rather than in a set of single tubes, and both the cDNA and biotin-labeled cRNA are purified using filter plates suitable for such a multiple-compartment format container.
  • the invention also is easily adaptable for automation, thereby cutting the time and expense even more.
  • the invention disclosed herein describes a method of generating substantially pure cDNA or cRNA in a multiple-compartment container, comprising dispensing at least one total or poly A+ RNA sample into the multiple-compartment container, synthesizing cDNA using the RNA as a template, and transferring the synthesized cDNA to a multiple-compartment filter unit.
  • the substantially pure cDNA is then transcribed in vitro and the reaction mixture transferred to a multiple-compartment filter unit to obtain substantially pure cRNA.
  • This invention is directed to the generation and purification, in a multiple- compartment format, of labeled and unlabeled polynucleotides, such as biotinylated cRNA, which are suitable as targets for gene expression analysis.
  • labeled and unlabeled polynucleotides such as biotinylated cRNA
  • a large number of samples can be processed in less time than a single sample using current methods.
  • one operator can generate up to 96 biotinylated targets in two days' time, whereas known prior art would allow only 25 to 30 samples to be processed in the same time period.
  • sample manipulation via pipetting, etc. is minimized, thereby reducing the probability of operator-induced errors and variations.
  • All samples undergo cDNA synthesis and, when desired, in vitro transcription using common reagent cocktails, thereby increasing product uniformity and reproducibility.
  • the use of appropriate filters for purification improves the consistency and purity of the samples even further.
  • the present invention also permits the reduction of the reaction volume of the in vitro transcription step by 50%, leading to a significant cost reduction.
  • the present invention also allows the amplification of cDNA or RNA by using sub-microgram amounts of the starting RNA samples.
  • the first step of the method of this invention requires dispensing at least one RNA sample into at least one compartment of a multiple-compartment container.
  • a plurality of RNA samples are dispensed into individual compartments of the multiple-compartment container.
  • the multiple-compartment container has 96 compartments or wells.
  • Other exemplary multiple-compartment containers include 384 and 1536 multiple-compartment containers.
  • the starting total or poly A+ RNA where total RNA includes all species of RNA and polyA+ RNA includes any RNA with a polyA+ tail, may be prepared by a method known in the art.
  • the amount of the starting materials can vary, and advantageously may be less than what is currently thought to be necessary for the preparation of the end product using prior art methods.
  • the amount of sample RNA dispensed into each individual compartment is in the range of about 0.5 to about 10 ⁇ g, and more preferably is an amount of about 5 ⁇ g.
  • cDNA is then prepared from the RNA using techniques that are well known to those skilled in the art. For example, sample RNA in each compartment may be subjected to synthesis of first copy strand of cDNA, using reverse transcriptase and an oligo dT primer that does or does not incorporate the sequence of the T7 RNA polymerase promoter. After the first strand is synthesized, the second complementary strand is synthesized using T4 polymerase to produce cDNA. The synthesized product cDNA is then transferred to a multiple-compartment filter unit with a filter membrane that retains the product cDNA but does not bind such cDNA while allowing smaller molecules to pass through, thus forming substantially pure cDNA.
  • the filter membrane is a standard cast membrane that works on the principle of size exclusion such that it retains double stranded DNA that is longer than approximately 130-150 nucleotides. Nucleotide triphosphates and oligonucleotide primers pass readily through the membrane.
  • the multiple-compartment filter unit is a Millipore MultiScreen®-PCR Filter Plate, available from the Millipore Corporation, Bedford, Massachusetts.
  • the resulting purified product cDNA is then collected by adding an appropriate buffer to the multiple-compartment filter unit containing the unbound product cDNA, gently shaking the multiple-compartment filter unit to resuspend the cDNA in the buffer, and then recovering the buffer containing the pure product cDNA.
  • the buffer is 10 niM TRIS buffer.
  • the resulting substantially pure product is suitable for use in microarray screening and assays.
  • detection labels can be incorporated during this process.
  • detection labels can be incorporated in the cDNA during the synthesis of the first strand.
  • a non-radioactive label such as biotin or fluorescein can be incorporated by adding a labeled nucleotide in the synthesis reaction.
  • isotopically labeled nucleotide either non-radioactive or radioactive, may be incorporated during the synthesis of the first strand.
  • the resulting cDNA will be easily detectable by the virtue of such labels.
  • a chemically reactive group such as an allyl amine can be incorporated into the cDNA by adding an amino allyl-dNTP to the synthesis reaction. After cDNA synthesis, the DNA is modified with a labeling molecule that is reactive with the amino group.
  • the substantially pure cDNA may be used to form substantially pure cRNA. More specifically, the cDNA synthesized and made substantially pure as described above may then be transcribed with an RNA polymerase, such as T7 RNA polymerase. The synthesized product cRNA is then transferred to a multiple-compartment filter unit, such as Millipore MultiScreen®- PCR Filter Plate, to form substantially pure cRNA. This product is suitable for use in microarray screening and assays.
  • the substantially pure cRNA may be labeled for detection.
  • detection labels can be incorporated during the in vitro transcription.
  • a non-radioactive label such as biotin or fluorescein can be incorporated by adding a labeled nucleotide in the in vitro transcription reaction.
  • isotopically labeled nucleotide either non-radioactive or radioactive, may be incorporated during the in vitro transcription. The resulting substantially pure cRNA will be easily detectable by the virtue of such labels.
  • detection labels can be incorporated directly into double stranded DNA and employed in microarray hybridization reactions that lead to genetic analysis and resequencing results.
  • genomic DNA can be cut with a restriction enzyme that leads to fragments 200 - 1000 bases in length. These fragments are end-modified with an adapter and then subjected to PCR amplification.
  • the amplified DNA is partially digested with Dnase, end-labeled with a dd-NTP and terminal transferase.
  • the labeled DNA is then hybridized to a genetic analysis array that can detect, for example, single nucleotide polymorphisims (SNPs).
  • SNPs single nucleotide polymorphisims
  • DNA can be partially fragmented with DNase and then 3' end labeled with a labeled didioxy nucleoside triphosphate and terminal transferase.
  • the partially fragmented, labeled DNA is then passed through a multiple-compartment filter unit to form a substantially pure DNA.
  • Millipore MultiScreen®-PCR Filter Plate #MANU03010
  • Millipore MultiScreen® Resist Vacuum Manifold #MAVM0960R
  • 8-channel pipettors with 5-50 ⁇ l and 50- 300 ⁇ l capacities
  • Beckman Modular Reservoir-quarter module either #372788 or #372790
  • Vortex mixer with plate adapter
  • MicrosealTM 'A' film MJ Research
  • Polypropylene microtiter plate 96-well format or 48-well format, such as MJ Research #MAP-9601 (96-well) or #MAP-4801 (48-well); Nuclease-free H 2 O (Ambion #9938); V-bottom assay plate (Corning #9793); UV plate in a 96-well flat- bottom format (Corning #3536); Thermal cycler with a vortexer, accommodating 96- well format plates ; Tape sheets (Qiagen #19570 or comparable).
  • RNA samples were thawed at 65°C for 5 minutes.
  • Step 2 First strand synthesis:
  • a first strand cocktail was prepared by mixing the following amounts for each reaction: 5X 1 st strand buffer (such as Gibco #18057-018), 4.0 ⁇ l; lOOmM DTT, 2.0 ⁇ l; lOmM dNTPs, 1.0 ⁇ l; Rnase Inhibitor such as Rnase outTM (Gibco), 1.0 ⁇ l; reverse transcriptase such as Superscript IT RT (Gibco), 1.0 ⁇ l;
  • the cocktail was dispensed into a Beckman quarter-module reagent reservoir.
  • the microtiter plate prepared as in Step 1 was kept in the thermal cycler. The plate was unsealed and the film was disposed of, afterwards 9 ⁇ l cocktail was carefully aliquoted to each sample with an 8-channel pipettor, 5-50 ⁇ l, and mixed. 8. The plate was resealed with fresh "A' film and was incubated in the thermal cycler at 50°C for 1 hour.
  • Step 3 Second strand synthesis:
  • a second strand cocktail was prepared by mixing the following amounts of materials for each reaction: DEPC H 2 O, 83.5 ⁇ l; 5X 2 nd strand buffer such as Gibco # 10812-014, 30.0 ⁇ l; lOmM dNTPs, 3.0 ⁇ l; Bio-11 CTPs such as Enzo #43818 7.5 ⁇ l E. coli DNA Ligase, 1.0 ⁇ l; E. coli DNA Polymerase, 4.0 ⁇ l; Rnase H, 1.0 ⁇ l. (Total volume 130 ⁇ l). Enough cocktail was prepared for one more than the total number of reactions .
  • the cocktail was dispensed into a Beckman quarter-module reagent reservoir.
  • the plate was resealed and was incubated in the thermal cycler at 16°C for 2 hours.
  • the plate was resealed and was incubated in the thermal cycler at 16°C for 5 minutes.
  • the plate was removed from the thermal cycler and was placed immediately on ice.
  • Step 4 cDNA Purification: 16. Using an 8-channel pipettor, 150 ⁇ l nuclease-free H 2 O was transferred for each reaction to be purified to a MultiScreen®-PCR plate.
  • the manifold was connected to house vacuum and the samples were aspirated at 15" Hg for 20 minutes for each well to completely dry.
  • the plate was placed on a vortex mixer with a plate adapter and was vortexed to resuspend the samples.
  • the samples were diluted 1 to 20 and quantified.
  • the samples were transferred from the plate to properly labeled 1.5 ml snap-cap tubes for storage at - 80°C.
  • the cDNA samples were also transferred to a multiple- compartment container to serve as the templates for the in vitro transcription for amplification reaction.
  • SPRI refers to a cDNA purification method based on the binding of DNA or RNA to carboxylate-modified paramagnetic micro-particles.
  • the cRNAs resulting from the cDNAs prepared by the method of the present invention compared to a test tube - SPRI method or a multiple-compartment plate - SPRI method, yielded gene expression results that were characterized by higher average frequency values (measure of signal strength) and the detection of more genes (Table 2).
  • Multiple-compartment filter unit 1 12.8 5518 2 12.0 5099
  • Example 2 High-throughput protocol for generating Affymetrix® GeneChip ⁇ Targets (biotinylated cRNA) in 96-well format.
  • Millipore MultiScreen®-PCR Filter Plate #MANU03010
  • Millipore MultiScreen® Resist Vacuum Manifold #MAVM0960R
  • 8-channel pipettors 5-50 ⁇ l and 50 - 300 ⁇ l capacities
  • Beckman Modular Reservoir-quarter module either #372788 or #372790
  • Vortex mixer with plate adapter
  • MicrosealTM 'A' film MJ Research #MSA-5001
  • Polypropylene microtiter plate 96-well format or 48-well format
  • Nuclease-free H 2 O Ambion #9938
  • V-bottom assay plate Coming #9793
  • UV plate in a 96-well flat-bottom format Coming #3536
  • Thermal cycler with a vortexer accommodating 96-well format plates
  • Tape sheets Quality of 96-well format plates
  • Tape sheets Qiagen #19570 or comparable
  • RNA samples were thawed at 65°C for 5 minutes.
  • Reagents were dispensed into polypropylene microtiter plate in the following quantities: total RNA, 5 ⁇ g; T7/T24 primer (High-quality, purified, 10 pmol/ ⁇ l), 2 ⁇ l; BAC Pool IX, 2.0 ⁇ l, DEPC H 2 O, sufficient to make the total volume to 11.0 ⁇ l.
  • the plate was sealed with MicrosealTM 'A' film.
  • Step 2 First strand synthesis:
  • a first strand cocktail was prepared by mixing the following amounts for each reaction: 5X 1 st strand buffer such as Gibco #18057-018, 4.0 ⁇ l; lOOmM DTT, 2.0 ⁇ l; lOmM dNTPs, 1.0 ⁇ l; Rnase Inhibitor such as Rnase-outTM, 1.0 ⁇ l; reverse transcriptase such as Superscript II RT, 1.0 ⁇ l; (total 9.0 ⁇ l). Enough cocktail was prepared for five more reactions than the number of reactions planned. 6. The cocktail was dispensed into a Beckman quarter-module reagent reservoir. 7. The microtiter plate prepared as in Step 1 was kept in the thermal cycler. The plate was unsealed and the film was disposed of, and 9 ⁇ l cocktail was carefully aliquoted to each sample with an 8-channel pipettor, 5-50 ⁇ l, and mix.
  • 5X 1 st strand buffer such as Gibco #18057-018, 4.0
  • microtiter plate was resealed with fresh "A' film and was incubated in the thermal cycler at 50° C for 1 hour.
  • Step 3 Second strand synthesis:
  • a second strand cocktail was prepared by mixing the following amounts of materials for each reaction: DEPC H 2 O, 91.0 ⁇ l; 5X 2 nd strand buffer Gibco #
  • the cocktail was dispensed into a Beckman quarter-module reagent reservoir. 11. With the microtiter plate in thermal cycler, the plate was unsealed, 130 ⁇ l second strand cocktail was carefully aliquoted to each sample with an 8- channel pipettor, 50-300 ⁇ l, and mixed. 12. The plate was unsealed and was incubated in a thermal cycler at 16°C for 2 hours. 13. With the microtiter plate in the thermal cycler, the temperature was dropped to 4°C, the plate was unsealed, 2 ⁇ l T4 DNA polymerase was aliquoted to each sample with an 8-channel pipettor, 5-50 ⁇ l, and mixed. 14. The plate was resealed and was incubated in a thermal cycler at 16°C for 5 minutes.
  • microtiter plate was removed from the thermal cycler and was placed immediately on ice.
  • MultiScreen®-PCR plate was placed onto MultiScreen® Resist Vacuum Manifold.
  • Step 5 hi vitro transcription for amplification:
  • An TVT cocktail was prepared by mixing the following volumes for each reaction: DEPC H 2 O, 16.2 ⁇ l; 1 OX TVT buffer such as Ambion #8150G, 6 ⁇ l; r ⁇ TP mix #5, 6 ⁇ l; biotinylated UTP such as Bio-11 UTP, 2.4 ⁇ l; biotinylated CTP such as Bio-11 CTP, 2.4 ⁇ l; Rnase hihibitor, 2 ⁇ l; lOOmM DTT, 3 ⁇ l; T7 R ⁇ A Polymerase, 1 ⁇ l. (Total volume 40 ⁇ l.) Enough cocktail was prepared for one more than total number of reactions. 29.
  • the IVT cocktail was dispensed into a Beckman quarter-module reagent reservoir. 30. 40 ⁇ l TVT cocktail was carefully aliquoted to each well of a polypropylene microtiter plate containing 20 ⁇ l cleaned cD ⁇ A product with an 8-channel pipettor, 5-50 ⁇ l, and mixed. 31. The microtiter plate was sealed with MicrosealTM 'A' film.
  • the plate was incubated in a thermal cycler at 37°C for 16 hours.
  • microtiter plate containing IVT reaction product was removed from the thermal cycler. The plate was placed on ice if not purifying immediately. 34. 120 ⁇ l ⁇ uclease-free H 2 O was added to each sample with an 8-channel pipettor and mixed. 35. The samples were transferred to a MultiScreen®-PCR plate.
  • MultiScreen ⁇ -PCR plate was placed on a MultiScreen® Resist Vacuum Manifold. 38. The vacuum was set to 15" Hg and the plate was aspirated for 20 minutes.
  • the vacuum was increased to 25" Hg (or maximum house vacuum if it is below 25" Hg) and the plate was aspirated for 10 minutes or until wells were dry.
  • the plate was placed on a vortexer with a plate adapter, and the plate was vortexed to resuspend the samples.
  • the plate was covered and was placed on ice.
  • the samples were diluted 1 to 20 and quantified. The samples were then transferred from plate to properly labeled 1.5 ⁇ l snap-cap tubes for storage at
  • Multiple-compartment filter unit 1 18.42 6415

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

L'invention concerne un procédé permettant de produire des polynucléotides sensiblement purs dans un récipient à compartiments multiples qui utilise un filtre de purification à compartiments multiples. Elle concerne en particulier un procédé de production d'ADNc ou d'ARNc marqués à l'aide de biotine pour faciliter la détection.
EP04701455A 2003-01-15 2004-01-12 Nouveau procede a haut debit de production et de purification de cibles d'arnc marquees pour l'analyse de l'expression genique Withdrawn EP1583831A2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34240103A 2003-01-15 2003-01-15
US342401 2003-01-15
PCT/US2004/000538 WO2004065573A2 (fr) 2003-01-15 2004-01-12 Nouveau procede a haut debit de production et de purification de cibles d'arnc marquees pour l'analyse de l'expression genique

Publications (1)

Publication Number Publication Date
EP1583831A2 true EP1583831A2 (fr) 2005-10-12

Family

ID=32770201

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04701455A Withdrawn EP1583831A2 (fr) 2003-01-15 2004-01-12 Nouveau procede a haut debit de production et de purification de cibles d'arnc marquees pour l'analyse de l'expression genique

Country Status (4)

Country Link
EP (1) EP1583831A2 (fr)
AU (1) AU2004206206A1 (fr)
CA (1) CA2509512A1 (fr)
WO (1) WO2004065573A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8546457B2 (en) 2007-08-14 2013-10-01 Basf Se Method for the production of abrasive foams

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005003375A2 (fr) * 2003-01-29 2005-01-13 454 Corporation Procede d'amplification et de sequençage d'acides nucleiques
WO2007020847A1 (fr) 2005-08-19 2007-02-22 Sumitomo Bakelite Co., Ltd. PROCÉDÉ SERVANT À PRODUIRE DES CHAÎNES D'ADNc ET D'ARN ET SUPPORT IMMOBILISANT UN NUCLÉOTIDE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001271721A1 (en) * 2000-07-05 2002-01-14 Rosetta Inpharmatics, Inc. Methods for genetic interpretation and prediction of phenotype

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004065573A3 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8546457B2 (en) 2007-08-14 2013-10-01 Basf Se Method for the production of abrasive foams

Also Published As

Publication number Publication date
AU2004206206A1 (en) 2004-08-05
WO2004065573A2 (fr) 2004-08-05
CA2509512A1 (fr) 2004-08-05
WO2004065573A3 (fr) 2005-03-31

Similar Documents

Publication Publication Date Title
US11072819B2 (en) Methods of constructing small RNA libraries and their use for expression profiling of target RNAs
Šimková et al. Coupling amplified DNA from flow-sorted chromosomes to high-density SNP mapping in barley
US20070269825A1 (en) Method and kit for nucleic acid sequence detection
US20100022405A1 (en) Methods and Kits for Sense RNA Synthesis
US20200010893A1 (en) Barcoded dna for long-range sequencing
WO2006102309A2 (fr) Methodes, compositions et trousses de detection de micro-arn
CA2619105A1 (fr) Procedes et kits de syntheses d'arn de detection
WO2011003020A1 (fr) Procédés et compositions pour l'amplification d'acide nucléique
WO2020136438A9 (fr) Procédé et kit de préparation d'adn complémentaire
US20210363517A1 (en) High throughput amplification and detection of short rna fragments
AU2016403554A1 (en) Method for enriching target nucleic acid sequence from nucleic acid sample
US6852494B2 (en) Nucleic acid amplification
EP2252708B1 (fr) Contrôle internes non compétitifs destinés à être utilisés dans des essais d'acide nucléique
EP1583831A2 (fr) Nouveau procede a haut debit de production et de purification de cibles d'arnc marquees pour l'analyse de l'expression genique
US20240287505A1 (en) Methods and compositions for combinatorial indexing of bead-based nucleic acids
EP1608784B1 (fr) Amplification globale lineaire non biaisee d'acide nucleique
US20030099937A1 (en) Nucleic acid amplification
US20020072061A1 (en) Methods and compositions for use in synthesizing nucleic acids
WO2024048602A1 (fr) Composition tampon à utiliser en hybridation et procédé d'hybridation
Sakai et al. Microanalysis of gene expression in tissues using T7‐SAGE: serial analysis of gene expression after high‐fidelity T7‐based RNA amplification
CN117625595A (zh) 染色质可及性/转录组共检测试剂盒及其应用
CN118647729A (zh) 用于高通量标记细胞核酸分子的方法和试剂盒
WO2024059622A2 (fr) Méthodes d'amplification simultanée d'adn et d'arn
Golby et al. Identification of low-abundance differentially expressed transcripts using arrayed cDNA clones
Dafforn et al. 18 Ribo-SPIA™, a Rapid Isothermal RNA Amplification Method for Gene Expression Analysis

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050603

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070801